July 3, 1986 |
Beckman Instruments Inc. said Wednesday that it again is trimming the work force at its Fullerton headquarters--this time by 48 jobs, including 33 layoffs--in a move designed to cut costs and realign the company's support services structure. The company, a division of SmithKline Beckman Corp., already has laid off 144 workers in Orange County this year and has cut about 1,000 jobs from its county payroll since Beckman merged with Philadelphia-based SmithKline in 1982.
June 3, 1994
Beckman Instruments Inc. said Thursday that it has signed a dealer agreement to market its products in Vietnam. The dealer, Europ Continents, also buys and resells Beckman equipment in Laos and Cambodia. Fullerton-based Beckman makes diagnostic equipment for hospitals and bioresearch equipment for life sciences laboratories. The Asia-Pacific market, which makes up 13% of Beckman's business, is the fastest-growing region in the medical equipment industry, the company said.
September 16, 1989 |
Citing a worldwide slump in government spending on medical research programs, Beckman Instruments said Thursday it will eliminate about 150 positions, or 2% of its 7,400 jobs, by the end of the year. All the cuts will be in the company's bioanalytical group, which produces esoteric instruments used largely in university and government medical and biological research programs.
April 13, 1989 |
Beckman Instruments and Allergan Inc., two Orange County firms that joined the company now known as SmithKline Beckman Corp. over the last decade, will become independent once again as the pharmaceutical giant spins off the two businesses. SmithKline said it plans to turn over its Beckman and Allergan subsidiaries to its shareholders. SmithKline shareholders will be given one share of newly created Allergan stock for every two SmithKline shares they now own, and they'll get one share of Beckman stock for every 5.5 of their SmithKline shares.
May 10, 1993 |
Louis T. Rosso has been with Beckman Instruments for 35 years and has been at its helm since the medical instrument maker was spun off from SmithKline Beckman Corp. in 1989. Under Rosso's direction, Beckman has aggressively established itself in Europe and Asia. Because of the push into global markets, about 55% of the company's revenue comes from overseas sales. Rosso also has strong views about the effect of health care reforms on the medical device industry.
November 25, 1997 |
Beckman Instruments Inc. signed a five-year purchasing contract with AmeriNet Inc. to provide laboratory chemistry systems and supplies. Beckman estimates sales of $100 million over the five-year contract period. AmeriNet is a health-care purchasing organization. Fullerton-based Beckman Instruments provides instrument systems, chemistries, software and supplies.